Cristiano Ferrario Selected Research

tucatinib

1/2022	Novel Therapies for the Treatment of HER2-Positive Advanced Breast Cancer: A Canadian Perspective.
1/2021	Preservation of quality of life in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer treated with tucatinib or placebo when added to trastuzumab and capecitabine (HER2CLIMB trial).
1/2018	Tucatinib Combined With Ado-Trastuzumab Emtansine in Advanced ERBB2/HER2-Positive Metastatic Breast Cancer: A Phase 1b Clinical Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cristiano Ferrario Research Topics

Disease

16	Breast Neoplasms (Breast Cancer) 01/2022 - 09/2007
12	Neoplasms (Cancer) 01/2021 - 07/2009
5	Prostatic Neoplasms (Prostate Cancer) 02/2022 - 01/2020
4	Brain Neoplasms (Brain Tumor) 01/2022 - 01/2018
4	Triple Negative Breast Neoplasms 01/2021 - 12/2019
2	Diarrhea 01/2021 - 01/2018
2	Disease Progression 01/2021 - 01/2018
1	Inflammation (Inflammations) 06/2021
1	Febrile Neutropenia 01/2021
1	Anemia 01/2021
1	Neutropenia 01/2021
1	Leukopenia 01/2021
1	Pneumonia (Pneumonitis) 10/2020
1	Residual Neoplasm 01/2020
1	Polyploidy 12/2019
1	Epistaxis (Nosebleed) 01/2018
1	Headache (Headaches) 01/2018
1	Constipation 01/2018
1	Nausea 01/2018
1	Thrombocytopenia (Thrombopenia) 01/2018
1	Vomiting 01/2018
1	Fatigue 01/2018
1	Neoplasm Metastasis (Metastasis) 07/2015
1	Hypertension (High Blood Pressure) 05/2013
1	Diabetes Mellitus 05/2013
1	Cardiotoxicity 05/2013
1	Tics (Tic) 05/2013
1	Stomach Neoplasms (Stomach Cancer) 03/2013

Drug/Important Bio-Agent (IBA)

5	Trastuzumab (Herceptin)FDA Link 01/2022 - 02/2010
3	tucatinibIBA 01/2022 - 01/2018
3	Capecitabine (Xeloda)FDA Link 01/2022 - 01/2021
3	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2011
3	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2019 - 05/2013
3	Pharmaceutical PreparationsIBA 12/2019 - 02/2010
2	Docetaxel (Taxotere)FDA Link 02/2022 - 09/2007
2	Vinorelbine (Navelbine)FDA LinkGeneric 01/2021 - 01/2016
2	LigandsIBA 10/2020 - 07/2009
2	taxaneIBA 10/2020 - 01/2018
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2020 - 09/2007
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 03/2013
2	Circulating Tumor DNAIBA 01/2020 - 01/2019
2	Aromatase InhibitorsIBA 08/2015 - 07/2015
2	Biomarkers (Surrogate Marker)IBA 07/2015 - 02/2010
1	AndrogensIBA 12/2021
1	AlbuminsIBA 06/2021
1	Hemoglobins (Hemoglobin)IBA 06/2021
1	talazoparibIBA 01/2021
1	eribulin FDA Link 01/2021
1	Topoisomerase I InhibitorsIBA 01/2021
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2021
1	Immunoconjugates (Immunoconjugate)IBA 01/2021
1	Gemcitabine FDA Link 01/2021
1	Surface Antigens (Surface Antigen)IBA 01/2021
1	ErbB Receptors (EGF Receptor)IBA 01/2021
1	sacituzumab govitecanIBA 01/2021
1	atezolizumabIBA 10/2020
1	130-nm albumin-bound paclitaxelIBA 10/2020
1	AnthracyclinesIBA 10/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Insulin-Like PeptidesIBA 12/2019
1	Perilipin-1IBA 12/2019
1	Cell-Free Nucleic AcidsIBA 01/2019
1	Ado-Trastuzumab EmtansineIBA 01/2018
1	pertuzumabIBA 01/2018
1	human ERBB2 proteinIBA 01/2018
1	Tyrosine Kinase InhibitorsIBA 01/2018
1	Sorafenib (BAY 43-9006)FDA Link 01/2016
1	Antineoplastic Agents (Antineoplastics)IBA 08/2015
1	Paclitaxel (Taxol)FDA LinkGeneric 08/2015
1	thiamine triphosphorate (TTP)IBA 07/2015
1	Progesterone Receptors (Progesterone Receptor)IBA 07/2015
1	Angiotensin Receptor AntagonistsIBA 05/2013
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 05/2013
1	SmokeIBA 05/2013
1	Epirubicin (Ellence)FDA LinkGeneric 05/2013
1	Brefeldin AIBA 03/2013
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 03/2013
1	ThapsigarginIBA 03/2013
1	Prion ProteinsIBA 03/2013
1	Carrier Proteins (Binding Protein)IBA 03/2013
1	Messenger RNA (mRNA)IBA 03/2013
1	TunicamycinIBA 03/2013
1	Growth Factor ReceptorsIBA 02/2010
1	CXCR4 Receptors (CXCR4 Receptor)IBA 07/2009
1	Chemokine CXCL12IBA 07/2009
1	ChemokinesIBA 07/2009

Therapy/Procedure

7	Therapeutics 01/2022 - 01/2011
4	Drug Therapy (Chemotherapy) 01/2021 - 01/2016
3	Castration 02/2022 - 06/2021
2	Neoadjuvant Therapy 05/2021 - 01/2020
1	Adjuvant Chemotherapy 01/2020
1	Aftercare (After-Treatment) 01/2018
1	Radiotherapy 05/2013